Periscope Capital’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-464,450
Closed -$4.74M 829
2022
Q4
$4.74M Buy
464,450
+1,737
+0.4% +$17.5K 0.2% 192
2022
Q3
$4.62M Sell
462,713
-39,087
-8% -$388K 0.13% 306
2022
Q2
$4.95M Hold
501,800
0.13% 313
2022
Q1
$4.94M Buy
+501,800
New +$4.93M 0.13% 323

Other funds holding PEPL

Periscope Capital's PEPL Position: Q1 2023 in Review

Periscope Capital sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 464,450 shares — an estimated $4.74M sold.

Periscope Capital first reported a position in PEPL in Q1 2022 and held it in 4 quarters. The position peaked at $4.95M in Q2 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

  • Periscope Capital reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • Periscope Capital sold 464,450 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $4.74M.
  • Periscope Capital first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q1 2022 and held it in 4 quarters.
  • Periscope Capital's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $4.95M in Q2 2022.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on Periscope Capital's 13F filing for Q1 2023, filed 12 May 2023.